These studies confirmed a decrease in Triad1 during AML latency in recipients of MLL1-ELL-transduced bone marrow and verified that Gcn1 mRNA was not altered by Triad1-knockdown or the time post-transplant. The gene discussed is KMT2A; the disease is acute myeloid leukemia.